NAGE FY 2014 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$392M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+50.7% YoY

Gross Profit

$5M34.8% margin

Operating Income

-$5M-34.2% margin

Net Income

-$5M-35.2% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$12M

Total Liabilities

$8M

Stockholders' Equity

$4M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$10M	+50.7%
Gross Profit	$5M	$3M	+70.0%
Operating Income	-$5M	-$4M	-19.3%
Net Income	-$5M	-$4M	-21.9%